OAM
VRTX icon

OP Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

OP Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7M Sell
26,189
-2,263
-8% -$1.06M 0.12% 117
2025
Q4 		$12.9M Buy
28,452
+164
+0.6% +$70.7K 0.15% 108
2025
Q3 		$11.1M Buy
28,288
+511
+2% +$214K 0.14% 118
2025
Q2 		$12.4M Buy
27,777
+347
+1% +$160K 0.18% 101
2025
Q1 		$13.3M Buy
+27,430
New +$12.8M 0.22% 84

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OP Asset Management's VRTX Position: Q1 2026 in Review

OP Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 8% in Q1 2026, selling an estimated $1.06M and leaving 26,189 shares worth $11.7M. The position accounts for 0.12% of the portfolio, ranked #117.

OP Asset Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $13.3M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • OP Asset Management held 26,189 shares of Vertex Pharmaceuticals worth $11.7M as of Q1 2026.
  • OP Asset Management sold 2,263 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.06M.
  • Vertex Pharmaceuticals made up 0.12% of OP Asset Management's portfolio in Q1 2026, its #117 holding.
  • OP Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • OP Asset Management's Vertex Pharmaceuticals position peaked at $13.3M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on OP Asset Management's 13F filing for Q1 2026, filed 9 Apr 2026.